The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for...
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding...
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that...
BeyondSpring, Inc. (NASDAQ: BYSI) Q1 2021 earnings call dated Jun. 16, 2021 Corporate Participants: Ashley R. Robinson — Media & Investor Relations...
After bringing the global economy to a grinding halt, the coronavirus pandemic is subsiding in most regions, thanks to the...
For pharmaceutical companies, 2020 was a busy year when the healthcare sector went into overdrive to deal with the challenges...
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q1 2021 earnings call dated May. 14, 2021 Corporate Participants: Will O’Connor — Investor Relations, Stern Investor...
Earlier this week, biotech company ImmunoGen (NASDAQ: IMGN) reported mixed financial results for the first quarter of 2021, pushing the...
Veru Inc. (NASDAQ: VERU) Q2 2021 earnings call dated May. 12, 2021 Corporate Participants: Sam Fisch — Director of Investor Relations Mitchell...
FibroGen Inc. (NASDAQ: FGEN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Michael Tung — Vice President of Corporate Strategy...
Immunogen, Inc. (NASDAQ: IMGN) Q1 2021 earnings call dated May. 10, 2021 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications...
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q1 2021 earnings call dated May. 06, 2021 Corporate Participants: Justin Holko — Vice President, Investor Relations...
Shares of Moderna Inc. (NASDAQ: MRNA) were down 3% in morning hours on Thursday despite the company reporting the first...
After being hit by the virus-induced slowdown in store footfall initially, CVS Health Corporation (NYSE: CVS) has regained the lost...
AbbVie Inc. (NYSE: ABBV) has long been fighting to delay the entry of generic alternatives to Humira, the pharma giant’s...
Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) Q1 2021 earnings call dated Apr. 29, 2021 Corporate Participants: Traci McCarty — Vice President of Investor...
Bristol-Myers Squibb Company (NYSE: BMY) reported first quarter 2021 earnings results today. Revenues increased 3% year-over-year to $11.1 billion. Net...
Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today. Total revenues decreased 24% year-over-year to $2.6 billion. On...
After dominating the cystic fibrosis market for quite some time, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is currently expanding its clinical...
The growing demand for new therapeutic solutions and advanced research in areas like human-genome will keep the biotechnology industry busy...
The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely...
